Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 5Recruiting 4Active not recruiting 3Unknown 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Carcinoma in Situ 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Mastectomy, Subcutaneous × Clear all
NCT02311959 2026-04-14

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed
450 enrolled
Breast

Breast Neoplasms, Carcinoma in Situ

NCT02891759 2023-05-06

Compare Outcomes Between Two Acellular Dermal Matrices

Washington University School of Medicine

Phase 2 Completed
320 enrolled
Breast

Breast Neoplasms

NCT01002014 2022-04-21

Nipple Sparing Mastectomy - Cosmetic Outcomes

Wake Forest University Health Sciences

Phase NA Completed
75 enrolled
Breast

Breast Neoplasms

NCT04640454 2020-11-23

Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer

Alexandria University

Completed
35 enrolled
Breast

Breast Neoplasms

NCT02061527 2018-04-24

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

Karolinska University Hospital

Phase NA Completed
135 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡